APA (7th ed.) Citation

MM, M., MM, H., HE, E., AE, F., MM, S., LA, R., & OM, A. (2025). Protective effect of Galectin-3 inhibitor against cardiac remodelling in an isoprenaline-induced myocardial infarction in type 2 diabetes. Archives of physiology and biochemistry, 131(1), 94. https://doi.org/10.1080/13813455.2024.2387710

Chicago Style (17th ed.) Citation

MM, Mahmoud, Hassan MM, Elsayed HE, Fares AE, Saber MM, Rashed LA, and Abdelwahed OM. "Protective Effect of Galectin-3 Inhibitor Against Cardiac Remodelling in an Isoprenaline-induced Myocardial Infarction in Type 2 Diabetes." Archives of Physiology and Biochemistry 131, no. 1 (2025): 94. https://doi.org/10.1080/13813455.2024.2387710.

MLA (9th ed.) Citation

MM, Mahmoud, et al. "Protective Effect of Galectin-3 Inhibitor Against Cardiac Remodelling in an Isoprenaline-induced Myocardial Infarction in Type 2 Diabetes." Archives of Physiology and Biochemistry, vol. 131, no. 1, 2025, p. 94, https://doi.org/10.1080/13813455.2024.2387710.